Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Biomolecules · 2023
DOI: 10.3390/biom13071039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Stanley Du Preez und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute, Griffith University, Gold Coast 4215, Australia. Hauptthemen laut MEDLINE: Fatigue Syndrome, Chronic, TRPM Cation Channels, Transient Receptor Potential Channels. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stafford Fox Medical Research Foundation, National Health and Medical Research Council, Ian and Talei Stewart, McCusker Charitable Foundation.
Abstract (Originalsprache)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling multisystemic condition. The pathomechanism of ME/CFS remains unestablished; however, impaired natural killer (NK) cell cytotoxicity is a consistent feature of this condition. Calcium (Ca2+) is crucial for NK cell effector functions. Growing research recognises Ca2+ signalling dysregulation in ME/CFS patients and implicates transient receptor potential ion channel dysfunction. TRPM7 (melastatin) was recently considered in the pathoaetiology of ME/CFS as it participates in several Ca2+-dependent processes that are central to NK cell cytotoxicity which may be compromised in ME/CFS. TRPM7-dependent Ca2+ influx was assessed in NK cells isolated from n = 9 ME/CFS patients and n = 9 age- and sex-matched healthy controls (HCs) using live cell fluorescent imaging techniques. Slope (p < 0.05) was significantly reduced in ME/CFS patients compared with HCs following TRPM7 activation. Half-time of maximal response (p < 0.05) and amplitude (p < 0.001) were significantly reduced in the HCs compared with the ME/CFS patients following TRPM7 desensitisation. Findings from this investigation suggest that TRPM7-dependent Ca2+ influx is reduced with agonism and increased with antagonism in ME/CFS patients relative to the age- and sex-matched HCs. The outcomes reported here potentially reflect TRPM3 dysfunction identified in this condition suggesting that ME/CFS is a TRP ion channelopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute, Griffith University, Gold Coast 4215, Australia.
- Consortium Health International for Myalgic Encephalomyelitis, Menzies Health Institute Queensland, Griffith University, Gold Coast 4215, Australia.
- School of Pharmacy and Medical Sciences, Griffith University, Gold Coast 4215, Australia.
- School of Medicine and Dentistry, Griffith University, Gold Coast 4215, Australia.
- Queensland Allergy Services, Gold Coast 4215, Australia.
Förderung
- Stafford Fox Medical Research Foundation
- National Health and Medical Research Council
- Ian and Talei Stewart, McCusker Charitable Foundation
- Buxton Foundation
- Henty Community
- Henty Lions Club
- Mason Foundation
- Blake Beckett Trust Foundation
Zitieren
APA
Du Preez, S., Eaton-Fitch, N., Smith, P. K., & Marshall-Gradisnik, S. (2023). Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Biomolecules. https://doi.org/10.3390/biom13071039
Vancouver
Du Preez S, Eaton-Fitch N, Smith PK, Marshall-Gradisnik S. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Biomolecules. 2023. doi:10.3390/biom13071039
BibTeX
@article{DuPreez2023,
author = {Du Preez, Stanley and Eaton-Fitch, Natalie and Smith, Peter K and Marshall-Gradisnik, Sonya},
title = {Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13071039}
}
EUVIMED